1.
New Immunological Markers of Thromboembolic and Hemorrhagic Complications after Coronary Artery Bypass Grafting. AJP [Internet]. 2017 Dec. 15 [cited 2026 Apr. 15];11(04). Available from:
http://www.asiapharmaceutics.info/index.php/ajp/article/view/1734